Patents by Inventor Mohammad Movassaghi

Mohammad Movassaghi has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • COMPOUNDS, COMPOSITIONS AND METHODS OF AGELASTATIN ALKALOIDS
    Publication number: 20170143708
    Abstract: The present invention, among other things, provides compounds, compositions and methods for treatment of cancer. In some embodiments, the present invention provides methods for treating blood cancer using agelastatin alkaloids.
    Type: Application
    Filed: September 2, 2016
    Publication date: May 25, 2017
    Applicants: Massachusetts Institute of Technology, The Board of Trustees of the University of Illinois
    Inventors: Mohammad Movassaghi, Paul J. Hergenrother
  • COMPOUNDS, CONJUGATES AND COMPOSITIONS OF EPIPOLYTHIODIKETOPIPERAZINES AND POLYTHIODIKETOPIPERAZINES
    Publication number: 20160354483
    Abstract: The present application provides, among other things, compounds, compositions and methods for treating various diseases including cancer.
    Type: Application
    Filed: May 10, 2016
    Publication date: December 8, 2016
    Applicants: Massachusetts Institute of Technology, The Board of Trustees of the University of Illinois
    Inventors: Mohammad Movassaghi, Justin Kim, Paul J. Hergenrother, Karen Morrison, Nicolas Boyer
  • Compounds, compositions and methods of agelastatin alkaloids
    Patent number: 9434736
    Abstract: The present invention, among other things, provides compounds, compositions and methods for treatment of cancer. In some embodiments, the present invention provides methods for treating blood cancer using agelastatin alkaloids.
    Type: Grant
    Filed: September 18, 2014
    Date of Patent: September 6, 2016
    Assignee: Massachusetts Institute of Technology
    Inventors: Mohammad Movassaghi, Paul J. Hergenrother
  • Substituted pyrazino[1?,2?:1 ,5]pyrrolo[2,3-b]-indole-1,4-diones for cancer treatment
    Patent number: 9353150
    Abstract: The present application provides, among other things, a compound of Formula I-a and/or I-b, or a pharmaceutically acceptable salt thereof, wherein the variables are defined in the specification. The compounds of the invention are useful for treating various diseases including cancer.
    Type: Grant
    Filed: December 4, 2013
    Date of Patent: May 31, 2016
    Assignees: Massachusetts Institute of Technology, The Board of Trustees of the University of Illinois
    Inventors: Mohammad Movassaghi, Justin Kim, Paul J. Hergenrother, Karen Morrison, Nicolas Boyer
  • COMPOUNDS, COMPOSITIONS AND METHODS OF AGELASTATIN ALKALOIDS
    Publication number: 20150080405
    Abstract: The present invention, among other things, provides compounds, compositions and methods for treatment of cancer. In some embodiments, the present invention provides methods for treating blood cancer using agelastatin alkaloids.
    Type: Application
    Filed: September 18, 2014
    Publication date: March 19, 2015
    Inventors: Mohammad Movassaghi, Paul J. Hergenrother
  • COMPOUNDS, CONJUGATES AND COMPOSITIONS OF EPIPOLYTHIODIKETOPIPERAZINES AND POLYTHIODIKETOPIPERAZINES
    Publication number: 20140187500
    Abstract: The present application provides, among other things, compounds, compositions and methods for treating various diseases including cancer.
    Type: Application
    Filed: December 4, 2013
    Publication date: July 3, 2014
    Applicants: The Board of Trustees of the University of Illinois, Massachusetts Institute of Technology
    Inventors: Mohammad Movassaghi, Justin Kim, Paul J. Hergenrother